Study S001181

Assessing the Role of GLP-1 Receptor Agonist Semaglutide and Dual GLP-I/GIP Receptor Agonist Tirzepatide in Delaying Genetic Aging in Adult Obese Patients Using the iWatchAge Technology

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07293325
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 66
Start: 2025-06-02
Primary completion: 2027-04-02
Lead sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions: Adults With Simple Obesity
Interventions: DRUG:Semaglutide; DRUG:Tirzepatide; DRUG:Metformin
Results posted: FALSE

Registered primary outcomes

Change in DNA methylation-based biological age measured by iWatchAge [Baseline and Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.